ATE502042T1 - Neue substanzen mit physiologischer aktivität, verfahren zu deren herstellung und deren verwendung - Google Patents

Neue substanzen mit physiologischer aktivität, verfahren zu deren herstellung und deren verwendung

Info

Publication number: ATE502042T1
Authority: AT; Austria
Prior art keywords: production; physiological activity; new substances; glucoside; substance
Prior art date: 2001-02-08

Application number

AT01955626T

Other languages

English (en)

Inventor

Hajime Fujii

Takashi Nakagawa

Buxiang Sun

Original Assignee

Amino Up Chemical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-08

Filing date

2001-08-09

Publication date

2011-04-15

2001-08-09 Application filed by Amino Up Chemical Co Ltd filed Critical Amino Up Chemical Co Ltd

2011-04-15 Application granted granted Critical

2011-04-15 Publication of ATE502042T1 publication Critical patent/ATE502042T1/de

Links

238000004519 manufacturing process Methods 0.000 title abstract 2
239000000126 substance Substances 0.000 title abstract 2
230000001766 physiological effect Effects 0.000 title 1
229930182478 glucoside Natural products 0.000 abstract 2
150000008131 glucosides Chemical class 0.000 abstract 2
HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Chemical compound CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 abstract 2
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract 1
230000001965 increasing effect Effects 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/58—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Oncology (AREA)
Mycology (AREA)
Communicable Diseases (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Virology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Compounds Of Unknown Constitution (AREA)

AT01955626T 2001-02-08 2001-08-09 Neue substanzen mit physiologischer aktivität, verfahren zu deren herstellung und deren verwendung ATE502042T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2001031852		2001-02-08
PCT/JP2001/006860 WO2002062813A1 (en)	2001-02-08	2001-08-09	Novel substance having physiological activity, process for producing the same, and use

Publications (1)

Publication Number	Publication Date
ATE502042T1 true ATE502042T1 (de)	2011-04-15

Family

ID=18895876

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01955626T ATE502042T1 (de)	2001-02-08	2001-08-09	Neue substanzen mit physiologischer aktivität, verfahren zu deren herstellung und deren verwendung

Country Status (13)

Country	Link
US (2)	US6831067B2 (de)
EP (1)	EP1298137B1 (de)
JP (1)	JP4932128B2 (de)
KR (1)	KR100838939B1 (de)
CN (1)	CN1252079C (de)
AT (1)	ATE502042T1 (de)
AU (1)	AU2001277737B2 (de)
CA (1)	CA2404514C (de)
DE (1)	DE60144231D1 (de)
ES (1)	ES2360765T3 (de)
MX (1)	MXPA02010057A (de)
NZ (1)	NZ521796A (de)
WO (1)	WO2002062813A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2006104068A (ja) *	2004-09-30	2006-04-20	Kobayashi Pharmaceut Co Ltd	樹状細胞活性化剤
JP4693093B2 (ja) *	2005-01-27	2011-06-01	国立大学法人鹿児島大学	抗癌剤
JP2008228640A (ja) *	2007-03-20	2008-10-02	Kaneka Corp	糖鎖化合物の濃縮および／または精製方法
ES2341163B1 (es) *	2008-09-26	2011-05-11	Bioiberica, S.A.	Composiciones inmunoestimulantes.
CN102382155B (zh) *	2011-08-03	2013-08-28	中国农业科学院蜜蜂研究所	一种大米糖浆提取物及其用途
CN104761595A (zh) *	2014-01-03	2015-07-08	江苏中谱检测有限公司	大米糖浆中特征物smr的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3015654A (en) *	1959-12-10	1962-01-02	John E Hodge	Preparation of o-galactosylisomaltol
JPS54109960A (en)	1978-02-15	1979-08-29	Takuma Sasaki	1,3-beta-d-glucan derivative, its use and preparation
JPS55157517A (en) *	1978-12-29	1980-12-08	Chiyokichi Iizuka	Antiviral drug and its preparation
JPS6236009A (ja)	1985-08-05	1987-02-17	Hitachi Metals Ltd	熱分解型窒化硼素
JPH0688909A (ja)	1992-09-08	1994-03-29	Fuji Photo Film Co Ltd	複屈折フイルムの製造方法及び該複屈折フイルムを用いた液晶表示装置
JPH06135987A (ja) *	1992-10-29	1994-05-17	Kikkoman Corp	フラノン配糖体及びその製造法
JP3651697B2 (ja) *	1995-03-24	2005-05-25	株式会社アミノアップ化学	新規多糖体物質
US5560914A (en) *	1995-07-12	1996-10-01	Daiwa Pharmaceutical Co., Ltd.	Immunopotentiator and method of manufacturing the same
JP4102466B2 (ja)	1997-11-14	2008-06-18	株式会社アミノアップ化学	抗癌剤の副作用軽減剤
JP2001106637A (ja)	1999-10-04	2001-04-17	Amino Up Chemical Co Ltd	サイトカイン産生能評価方法、サイトカイン産生能回復剤組成物、その製造方法及び用途
EP1154022B1 (de)	1999-12-15	2010-10-13	Amino Up Chemical Co. Ltd.	Aus basidiomyceten-kultur stammende substanz, verfahren zur herstellung derselben und deren anwendung

2001
- 2001-08-09 ES ES01955626T patent/ES2360765T3/es not_active Expired - Lifetime
- 2001-08-09 CA CA002404514A patent/CA2404514C/en not_active Expired - Lifetime
- 2001-08-09 NZ NZ521796A patent/NZ521796A/en not_active IP Right Cessation
- 2001-08-09 WO PCT/JP2001/006860 patent/WO2002062813A1/ja not_active Ceased
- 2001-08-09 EP EP01955626A patent/EP1298137B1/de not_active Expired - Lifetime
- 2001-08-09 US US10/181,252 patent/US6831067B2/en not_active Expired - Lifetime
- 2001-08-09 DE DE60144231T patent/DE60144231D1/de not_active Expired - Lifetime
- 2001-08-09 AU AU2001277737A patent/AU2001277737B2/en not_active Expired
- 2001-08-09 AT AT01955626T patent/ATE502042T1/de not_active IP Right Cessation
- 2001-08-09 JP JP2002563165A patent/JP4932128B2/ja not_active Expired - Lifetime
- 2001-08-09 CN CNB018078001A patent/CN1252079C/zh not_active Expired - Lifetime
- 2001-08-09 KR KR1020027013462A patent/KR100838939B1/ko not_active Expired - Lifetime
- 2001-08-09 MX MXPA02010057A patent/MXPA02010057A/es active IP Right Grant
2004
- 2004-10-29 US US10/975,415 patent/US7169762B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US7169762B2 (en)	2007-01-30
MXPA02010057A (es)	2004-08-19
US20030045483A1 (en)	2003-03-06
EP1298137A4 (de)	2005-07-20
NZ521796A (en)	2004-04-30
JP4932128B2 (ja)	2012-05-16
KR20020093893A (ko)	2002-12-16
DE60144231D1 (de)	2011-04-28
JPWO2002062813A1 (ja)	2004-06-10
KR100838939B1 (ko)	2008-06-16
CA2404514C (en)	2009-10-27
US6831067B2 (en)	2004-12-14
CN1252079C (zh)	2006-04-19
US20050143341A1 (en)	2005-06-30
CN1422277A (zh)	2003-06-04
EP1298137B1 (de)	2011-03-16
AU2001277737B2 (en)	2007-12-06
ES2360765T3 (es)	2011-06-08
WO2002062813A1 (en)	2002-08-15
EP1298137A1 (de)	2003-04-02
CA2404514A1 (en)	2002-08-15

Legal Events

Date	Code	Title	Description
2011-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
IT1291113B1 (it)	1998-12-29	Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
HUT47575A (en)	1989-03-28	Process for production of piperasinal derivatives of purine and medical compositions containing them
BRPI0313694B8 (pt)	2021-05-25	derivados de pirazol, composição medicinal contendo os mesmos, seu uso medicinal e intermediários para sua produção
HK1045655A1 (zh)	2002-12-06	由二甲雙胍及伏降糖組合構成的藥劑成份
BG107092A (en)	2003-04-30	Diabetic nutritionals
WO2001032157A3 (en)	2002-01-24	Pharmaceutical composition comprising a combination of metformin and glibenclamide
BR0212369A (pt)	2004-08-17	Composição nutricional para controlar o nìvel de açúcar no sangue
AR023401A1 (es)	2002-09-04	Derivados de 1,4-benzotiazepina-1,1-dioxido sustituidos con restos de azucar, procedimientos para su preparacion, medicamentos que contienen estoscompuestos, y su empleo para preparar un medicamento
DE69029365D1 (de)	1997-01-23	Zuckerrübenpektine und ihre Anwendung für Esswaren
WO2004028344A3 (en)	2004-06-24	A monitoring system containing a hospital bed with integrated display
HUP9901652A3 (en)	2000-04-28	Use of piperidine-carboxylic acid derivatives for producing pharmaceutical compositions suitable for reducing blood glucose
WO2005116003A3 (de)	2006-01-05	Substituierte oxazol-benzoisothiazoldioxidderivate, verfahren zu deren herstellung und deren verwendung
DE60045095D1 (de)	2010-11-25	Ahren zur herstellung derselben und deren anwendung
CA2412789A1 (en)	2002-12-13	Compositions for improving mental concentration
ATE509276T1 (de)	2011-05-15	Diagnostische zusammensetzung für typ-2-diabetes und beeinträchtigte glucosetoleranz sowie verwendungsverfahren
ATE502042T1 (de)	2011-04-15	Neue substanzen mit physiologischer aktivität, verfahren zu deren herstellung und deren verwendung
IL164276A0 (en)	2005-12-18	Nuckeic acud nolecules encoding human kremen 1 andhuman kremen 2 and diagnostic and pharmaceutical compositions based thereon
ATE456664T1 (de)	2010-02-15	Verfahren zur herstellung von oligosaccharidketten
DE2708493A1 (de)	1977-09-01	Neues antibiotikum am-1042
WO2002043654A3 (en)	2002-09-06	Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions
NO20063860L (no)	2006-08-29	7-fenylamino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav samt deres anvendelse som legemidler
JP2001333695A (ja)	2001-12-04	糖尿病患者用ケーキ（カロリー１００）
Afshar et al.	2005	Evaluation of the effect of teaching on blood glucose in patients with Diabetes Mellitus
ERSOY et al.	2024	TECHNOLOGY AND BRICOLOGY IN INTENSIVE CARE NURSES
RU92013625A (ru)	1995-07-27	Лекарственное средство, стимулирующее эритроидный росток кроветворения при цитостатических миелодепрессиях